title: Re-challenging patients with oxaliplatin allergy: the successful use of a standardised pre-medication protocol in a single institute.
authors.affiliation: Department of Clinical Oncology, Queen Mary Hospital, Hong Kong Special Administrative Region, China.
authors.forename: S W K
authors.initials: SW
authors.lastname: Siu
authors.forename: W L
authors.initials: WL
authors.lastname: Chan
authors.forename: K Y
authors.initials: KY
authors.lastname: Liu
authors.forename: T S
authors.initials: TS
authors.lastname: Choy
authors.forename: T W
authors.initials: TW
authors.lastname: Leung
authors.forename: K H
authors.initials: KH
authors.lastname: Au
mesh_terms: D000328:Adult; D000368:Aged; D000707:Anaphylaxis / Q000139:chemically induced / Q000188:drug therapy; D000779:Anesthetics, Local / Q000008:administration & dosage; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D003907:Dexamethasone / Q000008:administration & dosage; D004155:Diphenhydramine / Q000008:administration & dosage; D004342:Drug Hypersensitivity / Q000188:drug therapy*; D005260:Female; D006635:Histamine H2 Antagonists / Q000008:administration & dosage; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000627:therapeutic use*; D000077150:Oxaliplatin; D011292:Premedication; D011899:Ranitidine / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D000779:Anesthetics, Local; D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D006635:Histamine H2 Antagonists; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D003907:Dexamethasone; D011899:Ranitidine; D004155:Diphenhydramine